Evidence map›Paper›PMID 41710662›Full record

ArticleFrontiers in oncology2026

Interpretable ADC-based radiomics models for differentiating hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Yun Zhang, Xiao Yin, Baowen Guo, Hongwu Yang, Zhongjie Huang

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yun Zhang *Department of Radiology, Shenzhen Longhua Maternity and Child Healthcare Hospital, Shenzhen, China.
Xiao Yin *Department of Radiology, Yueyang Central Hospital, Yueyang, Hunan, China.
Baowen GuoDepartment of Radiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Hongwu YangDepartment of Radiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Zhongjie HuangDepartment of Radiology, Shenzhen Longhua Maternity and Child Healthcare Hospital, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to develop interpretable machine learning (ML) models using apparent diffusion coefficient (ADC) radiomics to differentiate hepatocellular carcinoma (HCC) from intrahepatic cholangiocarcinoma (ICC). Methods: Radiomic features were extracted from ADC maps of 83 pathologically confirmed HCC and 46 pathologically confirmed ICC patients who underwent MRI examinations. The least absolute shrinkage and selection operator (LASSO) method selected essential features for five ML models: logistic regression (LR), random forest (RF), gaussian naive bayes (GNB), support vector machine (SVM), and k-nearest neighbors (kNN). external validation was performed using 20 HCC and 20 ICC cases from the cancer imaging archive (TCIA) public database. Model performance was assessed using the area under the receiver operating characteristic curve (AUROC), sensitivity, specificity, accuracy, F1 score, calibration plots, and decision curve analysis (DCA). The best-performing model was interpreted using shapley additive explanations (SHAP). Results: LASSO selected eight features. The models achieved training AUROCs of 0.84-0.95 and internal validation AUROCs of 0.78-0.91. The LR model demonstrated superior performance (training AUROC: 0.95; internal validation AUROC: 0.91; external validation AUROC: 0.85). Moreover, calibration plots and DCA confirmed that this model exhibited the best calibration and clinical utility. SHAP identified wavelet-LLL-firstorder-RootMeanSquared as the most impactful feature. Conclusions: The ADC-based LR model robustly differentiates HCC from ICC, with validated generalizability using public data, offering a promising non-invasive clinical tool.

Indexed as

apparent diffusion coefficienthepatocellular carcinomaimaging radiomicsintrahepatic cholangiocarcinomamachinelearning

Identifiers

PMID41710662
PMCPMC12909249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.